nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Author Index
|
|
|
2001 |
20 |
3S1 |
p. 108- 1 p. |
artikel |
2 |
Current methods of the U.S. Preventive Services Task Force
|
Harris, Russell P. |
|
2001 |
20 |
3S1 |
p. 21-35 15 p. |
artikel |
3 |
Evidence-based prevention and international collaboration
|
Feightner, John W |
|
2001 |
20 |
3S1 |
p. 5-6 2 p. |
artikel |
4 |
Introducing the third U.S. preventive services task force
|
Berg, Alfred O. |
|
2001 |
20 |
3S1 |
p. 3-4 2 p. |
artikel |
5 |
New USPSTF guidelines
|
Calonge, Ned |
|
2001 |
20 |
3S1 |
p. 7-9 3 p. |
artikel |
6 |
Screening adults for lipid disorders
|
Berg, Alfred O |
|
2001 |
20 |
3S1 |
p. 73-76 4 p. |
artikel |
7 |
Screening and treating adults for lipid disorders 2 1 Reprints are available from the AHRQ Web site at www.ahrq.gov/clinic/uspstfix.htm, through the National Guideline Clearinghouse (www.guideline/gov), or in print through the AHRQ Publications Clearinghouse (1-800-358-9295). 2 2 The USPSTF recommendations based on this evidence review can be found in Screening Adults for Lipid Disorders: Recommendations and Rationale, available elsewhere in this supplement and from the AHRQ Web site and clearinghouse.
|
Pignone, Michael P |
|
2001 |
20 |
3S1 |
p. 77-89 13 p. |
artikel |
8 |
Screening for bacterial vaginosis in pregnancy
|
Berg, Alfred O |
|
2001 |
20 |
3S1 |
p. 59-61 3 p. |
artikel |
9 |
Screening for bacterial vaginosis in pregnancy 2 1 Reprints are available from the AHRQ Web site at www.ahrq.gov/clinic/uspstfix.htm, through the National Guideline Clearinghouse (www.guideline.gov), or in print through the AHRQ Clearinghouse (1-800-358-9295). 2 2 The U.S. Preventive Services Task Force recommendations based on this evidence review can be found in Screening for Bacterial Vaginosis in Pregnancy: Recommendations and Rationale, available elsewhere in this supplement, and from the AHRQ Web site and clearinghouse.
|
Guise, Jeanne-Marie |
|
2001 |
20 |
3S1 |
p. 62-72 11 p. |
artikel |
10 |
Screening for chlamydial infection
|
Nelson, Heidi D |
|
2001 |
20 |
3S1 |
p. 95-107 13 p. |
artikel |
11 |
Screening for chlamydial infection 2 1 This statement summarizes the third U.S. Preventive Services Task Force (USPSTF) recommendations for screening for chlamydial infection and the supporting scientific evidence, and it updates the 1995 recommendations contained in the Guide to Clinical Preventive Services, second edition.1 Explanations of the ratings and of the strength of overall evidence are given in Appendix A and Appendix B, respectively. The complete information upon which this statement is based, including evidence tables and references, is available in the accompanying article, Screening for Chlamydial Infection2 and in the Systematic Evidence Review3 on this topic, which can be obtained through the USPSTF Web site (www.ahrq.gov/clinic/uspstfix.htm), through the National Guideline Clearinghouse (www.guideline.gov), or in print through the AHRQ Publications Clearinghouse (1-800-358-9295). 2 2 Reprints are available from the AHRQ Web site at www.ahrq.gov/clinic/uspstfix.htm, through the National Guideline Clearinghouse (www.guideline/gov), or in print through the AHRQ Publications Clearinghouse (1-800-358-9295).
|
Berg, Alfred O |
|
2001 |
20 |
3S1 |
p. 90-94 5 p. |
artikel |
12 |
Screening for skin cancer
|
Helfand, Mark |
|
2001 |
20 |
3S1 |
p. 47-58 12 p. |
artikel |
13 |
Screening for skin cancer 2 1 This statement summarizes the third U.S. Preventive Services Task Force (USPSTF) recommendations for screening for skin cancer and supporting scientific evidence, and updates the 1995 recommendations contained in the Guide to Clinical Preventive Services, second edition.1 Explanations of the ratings and of the strength of overall evidence are given in Appendix A and in Appendix B, respectively. The complete information upon which this statement is based, including evidence tables and references, is available in the accompanying article Screening for Skin Cancer2 and in the Systematic Evidence Review3 on this topic, which can be obtained through the USPSTF Web site (www.ahrq.gov/clinic/uspstfix.htm), through the National Guideline Clearinghouse (www.guideline.gov), or in print through the AHRQ Clearinghouse (1-800-358-9295). 2 2 Reprints are available from the AHRQ Web site at www.ahrq.gov/clinic/uspstfix.htm, through the National Guideline Clearinghouse (www.guideline.gov), or in print through the AHRQ Publications Clearinghouse (1-800-358-9295).
|
Berg, Alfred O |
|
2001 |
20 |
3S1 |
p. 44-46 3 p. |
artikel |
14 |
Subject Index
|
|
|
2001 |
20 |
3S1 |
p. 108- 1 p. |
artikel |
15 |
The agency for healthcare research and quality and the U.S. preventive services task force
|
Eisenberg, John M. |
|
2001 |
20 |
3S1 |
p. 1-2 2 p. |
artikel |
16 |
The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services
|
Saha, Somnath |
|
2001 |
20 |
3S1 |
p. 36-43 8 p. |
artikel |
17 |
The evolving role of prevention in health care
|
Woolf, Steven H. |
|
2001 |
20 |
3S1 |
p. 13-20 8 p. |
artikel |
18 |
The methodologic partnership of effectiveness reviews and cost-effectiveness analysis
|
Russell, Louise B |
|
2001 |
20 |
3S1 |
p. 10-12 3 p. |
artikel |